Roth Affirms Cytokinetics (CYTK) at 'Buy' Following Enrollment of First VIGOR-ALS Patient
Go back to Roth Affirms Cytokinetics (CYTK) at 'Buy' Following Enrollment of First VIGOR-ALS Patient| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 64.80 -2.02 (3.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.82 | 52 Week High | $13.18 | |||
| Open | $64.81 | 52 Week Low | $6.00 | |||
| Day High | $65.42 | P/E | N/A | |||
| Day Low | $63.90 | EPS | $-1.24 | |||
| Volume | 1,112,287 | |||||
